Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712 Dosing ongoing in first patients, consecutively moving to ...
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States.FDA agrees with the clinical protocol ...
Remepy, a pioneer in Hybrid Drugsâ„¢, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into ...
Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...
At the American Society of Clinical Oncology (ASCO) meeting, a phase III trial was presented evaluating whether routine brain ...
The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is entering a stable growth phase, driven by rising hospital demand for faster imaging workflows, AI-powered ...
FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial ...
Phase 2 is expected to be more complex than Phase 1, as cleanup crews deal with a part of the building that is structurally ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting, advanced imaging and artificial intelligence to better monitor how cancer ...
Nearly 100 years ago, a seemingly simple discovery revolutionized the microscope. The introduction of phase contrast, which ...
Abstract: Optical synthetic aperture imaging (OSAI) systems consist of multiple subapertures arranged in a specific spatial pattern to achieve high resolution imaging comparable to that of a large ...
Abstract: Millimeter-wave (mmW) automotive radar imaging technology has great potential in advanced driver assistance systems (ADAS). Existing super-resolution imaging methods can improve angular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results